Ruth Swann

Cancer waits, bespoke targets, measuring interval gaps, and more! We've been quizzing Jon Shelton, Lorna Wills, @RuthSwann & Dr Fahmina Fardus-Reid as they discuss how we identify areas for improvement in diagnostic pathways #CRUKEDConference24

Audit shows faster cancer diagnosis from 2014 to 2018. Read the findings of the National Cancer Diagnosis Audits for England doi.org/10.3399/BJGP.2…  Watch the 1-min video  @RuthSwann @garyabel @jana_witt @sarahiom65 @GLyratzopoulos @Gregrubin4 #PrimaryCare

Cancer: Improvements in the diagnostic process for cancer patients were found between 2014 and 2018 in English practices doi.org/10.3399/BJGP.2… @RuthSwann @garyabel @jana_witt @sarahiom65 @GLyratzopoulos @Gregrubin4 #PrimaryCare

Belatedly sharing this due to bad inbox juggling: Our descriptive paper on blood test use in #primarycare is out in @BJGPjournal - led by @BenCranfield2 and with valuable input from NCDA gurus @garyabel @RuthSwann Sean McPhail @Gregrubin4 @GLyratzopoulos bit.ly/3USDr0Y

1/12 With colleagues in 14 jurisdictions in 6 countries we have just published a study on the predictors and consequences of cancer diagnosis within 30 days after an emergency hospital admission (=emergency presentation) in @TheLancetOncol thelancet.com/pdfs/journals/… A🧵:

2 or 2: Also good to see our recent work in @TheLancetOncol ncbi.nlm.nih.gov/pubmed/31704137 (with @mmkoo12 @RuthSwann @garyabel @Gregrubin4 et al.) being cited as part of Chapter 4.

Our guest this month is @RuthSwann on Research Round-up #podcast. She talks about ‘The frequency, nature and impact of GP-assessed avoidable delays in a population-based cohort of cancer patients’. bit.ly/2T4AUTR #cancerresearch #comorbidities @GLyratzopoulos

Thousands of cancer patients are experiencing delays that could have been avoided po.st/gMxQ68